Royal Philips NV Sponsored ADR Stock

$24.03

2.55%

NYSE, Jul 11, 10:00 pm CET

ISIN

US5004723038

Symbol

PHG

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Technology

Industry

Electrical engineering

Overview Dividends Analysts Charts News Strategies

Royal Philips NV Sponsored ADR Stock price

$24.03

-20.56 46.11% 5Y

NYSE, Closing price Fri, Jul 11 2025

-0.63 2.55%

ISIN

US5004723038

Symbol

PHG

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Technology

Industry

Electrical engineering

Key metrics

Basic

Market capitalization

$23.7b

Enterprise Value

$31.1b

Net debt

$7.5b

Cash

$1.4b

Shares outstanding

925.1m

Valuation (TTM | estimate)

P/E

52.2 | 13.5

P/S

1.1 | 1.1

EV/Sales

1.5 | 1.4

EV/FCF

negative

P/B

1.7

Dividends

DPS

$0.97

Yield 1Y | 5Y

4.0% | 1.8%

Growth 1Y | 5Y

100.0% | -

Payout 1Y | 3Y

-109.9% | -28.2%

Increased

1 Year

Financials (TTM | estimate)

Revenue

$21.0b | $21.9b

EBITDA

$3.7b | $3.4b

EBIT

$1.8b | $2.2b

Net Income

$436.0m | $1.6b

Free Cash Flow

$-261.8m

Growth (TTM | estimate)

Revenue

-0.9% | 3.8%

EBITDA

- | 25.2%

EBIT

524.5% | 99.3%

Net Income

146.6% | 300.7%

Free Cash Flow

Financial Health

Equity Ratio

41.4%

Return on Equity

-5.9%

ROCE

7.4%

ROIC

1.5%

Debt/Equity

0.6

EPS

$0.5

FCF per Share

$-0.3

Short interest

0.1%

Employees

67k

Rev per Employee

$320.0k

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Get Started for Free Today

Royal Philips NV Sponsored ADR Stock Analysis

Unlock Scores for Free

??

26 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

13x Buy

50%

13x Hold

50%

More details on Analyst Estimates Including Price Targets

26 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

Buy

50%

Hold

50%

Analyst Estimates with Stock Price Targets

Financial data from Royal Philips NV Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	21,017 21,017	1% 1% 100%
- Direct Costs	11,891 11,891	4% 4% 57%
Gross Profit	9,126 9,126	4% 4% 43%
- Selling and Administrative Expenses	5,943 5,943	1% 1% 28%
- Research and Development Expense	2,088 2,088	0% 0% 10%
EBITDA	3,709 3,709	- 18%
- Depreciation and Amortization	1,947 1,947	- 9%
EBIT (Operating Income) EBIT	1,762 1,762	525% 525% 8%
Net Profit	436 436	147% 147% 2%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Royal Philips NV Sponsored ADR Stock News

Neutral

GlobeNewsWire

●

7 days ago

Unlock Smarter Living for Less: Best-Selling Philips Smart Lock Drops to $94.99 for Prime Day 2025

From July 8 to 13, Amazon shoppers can score up to 50% off the brand's best-selling smart locks — including the Philips 4200 Series Built-in Wi-Fi Fingerpr

Neutral

Business Wire

●

19 days ago

Methodist Hospitals Selects Philips to Advance Neurovascular, Cardiology and Complex Interventional Radiology Services in Northwest Indiana

CAMBRIDGE, Mass. & GARY, Ind.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Methodist Hospitals today announced the healthcare provider's strategic investment in Philips' advanced portfolio of image-guided therapy (IGT) solutions that integrate imaging systems and software, with specialized diagnostic and therapeutic devices. The new intervent...

Neutral

GlobeNewsWire

●

about one month ago

Philips Foundation 2024 Annual Report: expanding access to quality healthcare for 46.5 million people

Amsterdam, the Netherlands – Marking its tenth anniversary, Philips Foundation today released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around the world – a significant increase from 28 million the year before. This progress was driven by 22 new initiatives and five new early-stage capital impa...

More Royal Philips NV Sponsored ADR News

Company Profile

Royal Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Respiratory Care businesses. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Head office	Netherlands
CEO	Roy Jakobs
Employees	66,678
Founded	1891
Website	www.philips.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now